NO882134L - Fremstilling av flunarizinholdige preparater. - Google Patents

Fremstilling av flunarizinholdige preparater.

Info

Publication number
NO882134L
NO882134L NO882134A NO882134A NO882134L NO 882134 L NO882134 L NO 882134L NO 882134 A NO882134 A NO 882134A NO 882134 A NO882134 A NO 882134A NO 882134 L NO882134 L NO 882134L
Authority
NO
Norway
Prior art keywords
flunarizin
preparation
containing preparations
alcohol
oil
Prior art date
Application number
NO882134A
Other languages
English (en)
Other versions
NO882134D0 (no
Inventor
Jean Mesens
Achiel Paul Van Peer
Josef Jan Pieter Heykants
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO882134D0 publication Critical patent/NO882134D0/no
Publication of NO882134L publication Critical patent/NO882134L/no

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fertilizers (AREA)
NO882134A 1987-05-18 1988-05-16 Fremstilling av flunarizinholdige preparater. NO882134L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5064487A 1987-05-18 1987-05-18

Publications (2)

Publication Number Publication Date
NO882134D0 NO882134D0 (no) 1988-05-16
NO882134L true NO882134L (no) 1988-11-21

Family

ID=21966482

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882134A NO882134L (no) 1987-05-18 1988-05-16 Fremstilling av flunarizinholdige preparater.

Country Status (19)

Country Link
EP (1) EP0292050B1 (no)
JP (1) JPS63303926A (no)
KR (1) KR880013559A (no)
AT (1) ATE69555T1 (no)
AU (1) AU603895B2 (no)
DE (1) DE3866281D1 (no)
DK (1) DK268788A (no)
ES (1) ES2051827T3 (no)
FI (1) FI882307A (no)
GR (1) GR3003482T3 (no)
HU (1) HU199073B (no)
IE (1) IE60937B1 (no)
IL (1) IL86395A (no)
NO (1) NO882134L (no)
NZ (1) NZ224497A (no)
PH (1) PH24425A (no)
PT (1) PT87496B (no)
RU (1) RU1829935C (no)
ZA (1) ZA883492B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532002A (en) * 1989-08-17 1996-07-02 Cortecs Limited Gelatin pharmaceutical formulations
DE69013923T2 (de) * 1989-08-17 1995-03-16 Cortecs Ltd Arzneiformulierungen.
KR100371062B1 (ko) * 1992-11-27 2003-04-21 에프.에이치.포울딩 앤드 컴퍼니 리미티드 안정성이향상된주사가능한택솔조성물및이를제형화하는방법
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
FR2729307B1 (fr) * 1995-01-18 1997-04-18 Seppic Sa Utilisation d'esters d'acides gras ethoxyles comme composants auto-emulsionnables notamment utiles pour la preparation de produits de traitement phytosanitaires ou de medicaments a usage veterinaire ou humain
KR20010031520A (ko) * 1997-11-07 2001-04-16 스즈키 다다시 피페라진류-시클로덱스트린 복합체
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
BRPI0212341B8 (pt) * 2001-09-10 2021-05-25 Janssen R&D Ireland compostos intermediários de inibidores de protease de hiv e processo para preparação dos mesmos
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
US9717703B2 (en) 2009-10-16 2017-08-01 Glaxosmithkline Llc Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
CN104069086A (zh) * 2014-07-22 2014-10-01 周有财 一种盐酸氟桂利嗪组合物胶囊及其制备方法
CN113262207B (zh) * 2020-02-17 2022-06-17 正大青春宝药业有限公司 一种盐酸氟桂利嗪胶囊制剂及其制备方法
CN115381791B (zh) * 2022-09-21 2023-06-16 迪沙药业集团有限公司 一种盐酸氟桂利嗪药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
EP0366156B1 (de) * 1984-01-28 1995-01-11 Roshdy Dr. Ismail Mittel zur Behandlung von Erkrankungen der Venen und des Analbereichs
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US5047229A (en) * 1986-12-17 1991-09-10 Miles, Inc. Treatment of cardiovascular and cerebral toxicity using calcium modulators

Also Published As

Publication number Publication date
GR3003482T3 (en) 1993-02-17
DK268788D0 (da) 1988-05-17
FI882307A (fi) 1988-11-19
NO882134D0 (no) 1988-05-16
IL86395A0 (en) 1988-11-15
IE881477L (en) 1988-11-18
HU199073B (en) 1990-01-29
EP0292050B1 (en) 1991-11-21
KR880013559A (ko) 1988-12-21
FI882307A0 (fi) 1988-05-17
JPS63303926A (ja) 1988-12-12
DE3866281D1 (de) 1992-01-02
ZA883492B (en) 1990-01-31
AU1613288A (en) 1988-11-24
ATE69555T1 (de) 1991-12-15
AU603895B2 (en) 1990-11-29
NZ224497A (en) 1990-04-26
DK268788A (da) 1988-11-19
EP0292050A1 (en) 1988-11-23
IE60937B1 (en) 1994-09-07
PT87496B (pt) 1992-09-30
HUT46851A (en) 1988-12-28
ES2051827T3 (es) 1994-07-01
PT87496A (pt) 1989-05-31
RU1829935C (ru) 1993-07-23
IL86395A (en) 1992-11-15
PH24425A (en) 1990-06-25

Similar Documents

Publication Publication Date Title
NO882134D0 (no) Fremstilling av flunarizinholdige preparater.
AU652827B2 (en) Fatty acid compositions
PH21591A (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition
EP0384547A3 (en) Oxidation-resistant alimentary fatty compositions containing an active oxidation-preventing agent extracted from vegetable tissues
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
EP0341707A3 (en) Phenylethanol ester of ortho-cinnamic acid, its preparation and use as fragrance compound
EP0390930A4 (en) Stable aqueous preparation of active vitamin d 3?
DE69022314T2 (de) Stabile emulgierte Tretinoin-Cremeformulierungen.
AU2072088A (en) Agent containing salicylic acid for treating lepidosis
PH27567A (en) Topical compositions
KR880008795A (ko) 피부 화장료
JPS5772908A (en) Removing agent for make-up cosmetic
HUT49621A (en) Insecticides comprising thionophosphoric acid ester as active ingredient and process for producting the active ingredients
SE8401748D0 (sv) Antimykotiskt medel i form av krem med hoggradig frigoring av verksam substans
IT1211765B (it) Formulazioni idrosolubili di ubidecarenoni,procedimento per la loro preparazione e composizioni cosmetiche che li contengono
JPS5624484A (en) Antioxidant for fats and oils
GB1315275A (en) Insecticide
FR2597480B1 (fr) Derives d'esters phosphoriques et compositions insecticides et acaricides contenant ces derives.
ATE189383T1 (de) Schweisshemmende cremezusammensetzungen enthaltend triglycerid gelierungsmittel
RO95625A2 (ro) Crema cosmeticca vitaminizanta